OFFICIAL-SOURCE RECALL · UNITED KINGDOM
Class 2 Medicines : Crescent Pharma Limited, Ramipril 2.5 mg Recall: associated with this defect is
Use the identifiers printed on your item to determine whether this recall may affect the product you own.
CHECK THE ITEM YOU OWN
Is your product affected?
- Brand
- See official notice
- Product
- Class 2 Medicines Recall: Crescent Pharma Limited, Ramipril 2.5 mg Capsules, EL(26)A/25
- Manufacturer
- See official notice
- GTIN
- 05017123670138
- Lot number
- batch-numbers, Batch, GR155023, GR175026, stated, and, number, gr155023-outer-carton-cor, gr175026-representing-ima
- Batch number
- numbers, Numbers, GR155023, GR175026, stated, and, number, gr155023-outer-carton-cor, gr175026-representing-ima
- Date code
- date information can be found o, Date
- Expiration date
- date information can be found o, Date
The barcode may identify the product type, while the recall may apply only to certain lots, dates or variants. Check all identifiers listed in the official recall.
Why this product was recalled
associated with this defect is unintentional overdosing, where patients prescribed Ramipril 2.5 mg capsules may receive 10 mg capsules. Signs and symptoms may include feeling lightheaded, fainting, fatigue, or altered kidney function and be more serious for at risk or vulnerable patients. Healthcare professionals should be aware that only the Ramipril 2.5mg Capsules batch stated in this notification is impacted. Advice for Healthcare Professionals to Provide to Patients: Some cartons of Ramipril 2.5mg Capsules, manufactured by Crescent Pharma Limited, may contain blister strips of Ramipril 10 mg Capsules and are being recalled at the pharmacy level as a precautionary measure. If you were prescribed Ramipril 2.5 mg Capsules, and received a Crescent pack with batch number GR155023, please check the blister strips inside (the batch number and expiry date information can be found on outer carton, see the images in Annex 1). if the carton contains blister strips that are labelled as Ramipril 2.5 mg Capsules, you do not need to take further action and may continue to take the capsules if the carton contains a blister strip that is labelled as Ramipril 10 mg capsules, do not take the medi
Hazard
associated with this defect is unintentional overdosing, where patients prescribed Ramipril 2.5 mg capsules may receive 10 mg capsules. Signs and symptoms may include feeling lightheaded, fainting, fatigue, or altered kidney function and be more serious for at risk or vulnerable patients. Healthcare professionals should be aware that only the Ramipril 2.5mg Capsules batch stated in this notification is impacted. Advice for Healthcare Professionals to Provide to Patients: Some cartons of Ramipril 2.5mg Capsules, manufactured by Crescent Pharma Limited, may contain blister strips of Ramipril 10 mg Capsules and are being recalled at the pharmacy level as a precautionary measure. If you were prescribed Ramipril 2.5 mg Capsules, and received a Crescent pack with batch number GR155023, please check the blister strips inside (the batch number and expiry date information can be found on outer carton, see the images in Annex 1). if the carton contains blister strips that are labelled as Ramipril 2.5 mg Capsules, you do not need to take further action and may continue to take the capsules if the carton contains a blister strip that is labelled as Ramipril 10 mg capsules, do not take the medi
Official recall notice
Class 2 Medicines Recall: Crescent Pharma Limited, Ramipril 2.5 mg Capsules, EL(26)A/25
Agency: Medicines and Healthcare products Regulatory Agency
Official publication date: May 28, 2026
Read the official UK_MHRA recall notice →Scan products you own
Scan products you own once and let RecallGuard monitor future official recalls.
Scan & Monitor Products